BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thurman JM, Yapa R. Complement Therapeutics in Autoimmune Disease. Front Immunol 2019;10:672. [PMID: 31001274 DOI: 10.3389/fimmu.2019.00672] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Kolev M, Das M, Gerber M, Baver S, Deschatelets P, Markiewski MM. Inside-Out of Complement in Cancer. Front Immunol 2022;13:931273. [DOI: 10.3389/fimmu.2022.931273] [Reference Citation Analysis]
2 Chopra D, Arens RA, Amornpairoj W, Lowes MA, Tomic-canic M, Strbo N, Lev-tov H, Pastar I. Innate immunity and microbial dysbiosis in hidradenitis suppurativa – vicious cycle of chronic inflammation. Front Immunol 2022;13:960488. [DOI: 10.3389/fimmu.2022.960488] [Reference Citation Analysis]
3 Zhu Z, Li R, Yang Q, Tan B, Dong X, Chi S, Liu H, Zhang S. The Potential Advantage of Myo‐Inositol as a Dietary Supplement for Juvenile Hybrid Grouper (Brown‐Marbled Grouper Epinephelus fuscoguttatus ♀ × Giant Grouper Epinephelus lanceolatus ♂). N American J Aquac 2022;84:74-82. [DOI: 10.1002/naaq.10217] [Reference Citation Analysis]
4 Ruocco A, Sirico A, Novelli R, Iannelli S, Van Breda SV, Kyburz D, Hasler P, Aramini A, Amendola PG. The role of C5a-C5aR1 axis in bone pathophysiology: A mini-review. Front Cell Dev Biol 2022;10:957800. [DOI: 10.3389/fcell.2022.957800] [Reference Citation Analysis]
5 Schmidt C, Weißmüller S, Bohländer F, Germer M, König M, Staus A, Wartenberg-Demand A, Heinz CC, Schüttrumpf J. The Dual Role of a Polyvalent IgM/IgA-Enriched Immunoglobulin Preparation in Activating and Inhibiting the Complement System. Biomedicines 2021;9:817. [PMID: 34356880 DOI: 10.3390/biomedicines9070817] [Reference Citation Analysis]
6 Rahiman N, Markina YV, Kesharwani P, Johnston TP, Sahebkar A. Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases. J Control Release 2022;348:264-86. [PMID: 35649486 DOI: 10.1016/j.jconrel.2022.05.046] [Reference Citation Analysis]
7 Thurman JM. Complement and the Kidney: An Overview. Adv Chronic Kidney Dis 2020;27:86-94. [PMID: 32553250 DOI: 10.1053/j.ackd.2019.10.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
8 Rushing BR, Rohlik DL, Roy S, Skaff DA, Garcia BL. Targeting the Initiator Protease of the Classical Pathway of Complement Using Fragment-Based Drug Discovery. Molecules 2020;25:E4016. [PMID: 32899120 DOI: 10.3390/molecules25174016] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Nasonov EL, Reshetnyak TM, Alekberova ZS. [Thrombotic microangiopathy in rheumatology: a link between thrombosis and autoimmunity]. Ter Arkh 2020;92:4-14. [PMID: 32598770 DOI: 10.26442/00403660.2020.05.000697] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Grunenwald A, Roumenina LT. The Benefits of Complement Measurements for the Clinical Practice. Methods Mol Biol 2021;2227:1-20. [PMID: 33847926 DOI: 10.1007/978-1-0716-1016-9_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Menon D, Barnett C, Bril V. Novel Treatments in Myasthenia Gravis. Front Neurol 2020;11:538. [PMID: 32714266 DOI: 10.3389/fneur.2020.00538] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Biewenga M, Farina Sarasqueta A, Tushuizen ME, de Jonge-Muller ESM, van Hoek B, Trouw LA. The role of complement activation in autoimmune liver disease. Autoimmun Rev 2020;19:102534. [PMID: 32234403 DOI: 10.1016/j.autrev.2020.102534] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
13 Chen JY, Galwankar NS, Emch HN, Menon SS, Cortes C, Thurman JM, Merrill SA, Brodsky RA, Ferreira VP. Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation. Front Immunol 2020;11:1460. [PMID: 32793201 DOI: 10.3389/fimmu.2020.01460] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Ricklin D, Mastellos DC, Lambris JD. Therapeutic targeting of the complement system. Nat Rev Drug Discov 2019. [PMID: 31819218 DOI: 10.1038/s41573-019-0055-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
15 Hosseini P, Fallahi MS, Erabi G, Pakdin M, Zarezadeh SM, Faridzadeh A, Entezari S, Ansari A, Poudineh M, Deravi N. Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities. Front Mol Biosci 2022;9:804109. [DOI: 10.3389/fmolb.2022.804109] [Reference Citation Analysis]
16 Xie CB, Jiang B, Qin L, Tellides G, Kirkiles-Smith NC, Jane-Wit D, Pober JS. Complement-activated interferon-γ-primed human endothelium transpresents interleukin-15 to CD8+ T cells. J Clin Invest 2020;130:3437-52. [PMID: 32191642 DOI: 10.1172/JCI135060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
17 Reséndiz-Mora A, Wong-Baeza C, Nevárez-Lechuga I, Landa-Saldívar C, Molina-Gómez E, Hernández-Pando R, Wong-Baeza I, Escobar-Gutiérrez A, Baeza I. Interleukin 4 deficiency limits the development of a lupus-like disease in mice triggered by phospholipids in a non-bilayer arrangement. Scand J Immunol 2021;93:e13002. [PMID: 33247472 DOI: 10.1111/sji.13002] [Reference Citation Analysis]
18 Sharma M, Vignesh P, Tiewsoh K, Rawat A. Revisiting the complement system in systemic lupus erythematosus. Expert Rev Clin Immunol 2020;16:397-408. [PMID: 32228236 DOI: 10.1080/1744666X.2020.1745063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
19 Patriquin CJ, Kuo KHM. Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics. Transfus Med Rev 2019;33:256-65. [PMID: 31703946 DOI: 10.1016/j.tmrv.2019.09.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]